CM Life Sciences (CMLFU) Stock Price, News & Analysis

Company Overview

CM Life Sciences Inc. is a special purpose acquisition company formed to identify and acquire one or more businesses in the life sciences sector. The company’s primary activity is to conduct a business combination with a target that offers innovative solutions in biotechnology, pharmaceuticals or medical devices. Through its acquisition vehicle structure, CM Life Sciences seeks to leverage public market access and strategic expertise to support growth-stage life sciences companies in advancing their research and development initiatives.

Incorporated in Delaware in early 2021, CM Life Sciences completed its initial public offering in April 2021, raising approximately $200 million through the sale of units. Each unit consisted of one share of common stock and one-half warrant, with the offering proceeds held in trust pending the identification and completion of a qualifying business combination. The company’s management team brings experience in capital markets, corporate finance and the life sciences industry, positioning CM Life Sciences to execute a timely and value-generating merger.

Headquartered in New York, CM Life Sciences operates with a focus on North American life sciences targets but retains the flexibility to pursue opportunities globally. Its leadership team, supported by advisors and industry veterans, conducts rigorous due diligence to evaluate potential partners’ scientific pipelines, regulatory pathways and commercial prospects. By combining capital resources with operational guidance, CM Life Sciences aims to accelerate the development and commercialization of novel therapies and technologies.

Key Stats

• Today's Range: $13.00 to $13.31
• 50-Day Range: $13.00 to $13.00
• 52-Week Range: $10.00 to $30.80
• Volume: 1,300 shs
• Average Volume: 77,370 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CMLFU Stock Analysis - Frequently Asked Questions

How have CMLFU shares performed this year?

CM Life Sciences' stock was trading at $13.00 on January 1st, 2025. Since then, CMLFU stock has increased by 0.0% and is now trading at $13.00.

How do I buy shares of CM Life Sciences?

Shares of CMLFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Business Services
• Industry: Services – Health
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:CMLFU
• CIK: N/A
• Web: cmlifesciencesspac.com
• Phone: 212 474 6745
• Fax: N/A
• Employees: 1,200
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A